ATLASCreative Medical Technology (CELZ) earnings date: Nov 6, 2026
Creative Medical Technology (CELZ) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026. Analysts expect EPS of -$0.24.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CELZ
| Last price | $0.65 (-3.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.0% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Creative Medical Technology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Creative Medical Technology reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Creative Medical Technology. You can switch it off at any time.
Alert me before CELZ reportsFree to start. Creating an account takes under a minute.
Notify me when Creative Medical Technology reports
Track CELZ free Add Creative Medical Technology to a free ATLAS watchlist and see its next report date in one place.
CELZ earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.24 |
| Last report | Aug 7, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -22.5% |
| Average move around a report | ±4.6% (last 5) |
| Sector | Healthcare · Biotechnology |
Creative Medical Technology earnings history: last 5 reports
Creative Medical Technology last reported on Aug 7, 2026: EPS of -$0.41 against an estimate of -$0.39 (-5.1% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 7, 2026 | -$0.39 | -$0.41 | -5.1% | Miss | +4.4% |
| May 8, 2026 | -$0.39 | -$0.38 | +2.6% | Beat | -4.8% |
| Mar 20, 2026 | -$0.37 | -$0.80 | -116.2% | Miss | -1.1% |
| Feb 26, 2026 | $0.32 | $0.34 | +6.3% | Beat | -2.2% |
| Nov 7, 2025 | -$0.48 | -$0.48 | 0.0% | In line | +10.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CELZ
See the fair value, the probability range and the earnings history of Creative Medical Technology on its ATLAS page.
Creative Medical Technology (CELZ) stock analysisPlans from €3.99 a month.
Creative Medical Technology earnings: frequently asked questions
When does Creative Medical Technology (CELZ) report earnings?
Creative Medical Technology is scheduled to report on Friday, November 6, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CELZ?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.24 per share (USD). Estimates can change before the report.
How often does CELZ beat earnings estimates?
Of its last 5 reports with a recorded result, Creative Medical Technology beat the EPS estimate 2 times; the average surprise was -22.5%. Past results do not predict the next one.
How much does CELZ move around earnings?
Over its last 5 reports the stock moved an average of 4.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Creative Medical Technology beat earnings estimates last quarter?
Creative Medical Technology last reported on Aug 7, 2026: EPS of -$0.41 against an estimate of -$0.39 (-5.1% surprise), a miss.
How much does CELZ usually move in a day?
On a normal trading day the ATLAS model puts CELZ’s one-day range at about ±5.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer